ProShares Ultra Health Care
RXL
16 hedge funds and large institutions have $6.64M invested in ProShares Ultra Health Care in 2017 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 6 reducing their positions, and 3 closing their positions.
0% more funds holding
Funds holding: 16 → 16 (0)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
0.1% less ownership
Funds ownership: 7.31% → 7.22% (-0.1%)
15% less capital inflows, than outflows
Capital inflows: $1.89M | Capital outflows: $2.22M
83% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geneos Wealth Management
Englewood,
Colorado
|
+$1.15M |
| 2 |
Toth Financial Advisory
Leesburg,
Virginia
|
+$671K |
| 3 |
BRC
Bell Rock Capital
Rehoboth Beach,
Delaware
|
+$62.7K |
| 4 |
CAPTRUST Financial Advisors
Raleigh,
North Carolina
|
+$7.37K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.07M |
| 2 |
Jane Street
New York
|
-$643K |
| 3 |
Virtu KCG Holdings
New York
|
-$396K |
| 4 |
Tower Research Capital (TRC)
New York
|
-$46K |
| 5 |
Advisor Group
Phoenix,
Arizona
|
-$31.4K |
RXL Hedge Fund Activity: Q2 2017 in Review
16 of the 4,023 institutional investors tracked by Wall St. Rank reported a position in ProShares Ultra Health Care (RXL) for Q2 2017, worth a combined $6.64M — up 7.8% from $6.16M a quarter earlier.
Fund positioning in RXL was balanced in Q2 2017: 3 funds opened new positions, 3 closed out, 1 added to existing stakes and 6 trimmed.
The largest buyer was Geneos Wealth Management, opening a new position worth an estimated $1.15M. The largest seller was Susquehanna International Group, cutting an estimated $1.07M.
- 16 institutional investors held ProShares Ultra Health Care (RXL) as of Q2 2017, unchanged from Q1 2017.
- Funds reported $6.64M of ProShares Ultra Health Care stock for Q2 2017, up 7.8% quarter-over-quarter.
- 3 funds opened new ProShares Ultra Health Care positions in Q2 2017 and 3 closed out, a net change of 0 holders.
- The largest ProShares Ultra Health Care buyer in Q2 2017 was Geneos Wealth Management, an estimated $1.15M added.
- The largest ProShares Ultra Health Care seller in Q2 2017 was Susquehanna International Group, an estimated $1.07M sold.
Based on aggregated 13F filings for Q2 2017.